We provide a digital platform called MacuTest to predict your risk of progressing to the advanced stages of Age-related Macular Degeneration (AMD), a blinding and incurable disease.
According to your risk, we provide you with personalised lifestyle recommendations to help you preserve your vision.
Our technology was developed by the Eye Risk consortium in the framework of the European program Horizon 2020.
www.eyerisk.eu
Company Details
- Employees
- 10
- Address
- 406, Boulevard Jean-Jacques Bosc, Bègles,nouvelle-Aquitaine 33130,france
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.macutest.com
- Keywords
- Montreal.
- HQ
- Bègles, Nouvelle-Aquitaine
Retinov Questions
Retinov's website is http://www.macutest.com
Retinov's LinkedIn profile is https://fr.linkedin.com/company/reti-nov
Retinov has
10 employees.
View email and phone details for 10
employees at Retinov.
Retinov's industry is
Hospitals and Health Care
Retinov's top competitors are
Leedana Sandponic,
Fulcra,
Tissuetinker,
Workcycle,
Scopia Surgical,
Gestion Toolbox,
Qalam Health Solutions,
Josephine Care,
Capcyte Biotherapeutics,
Catalum Technologies.
Retinov's categories are Hospitals and Health Care
